Free Trial

The Cigna Group (NYSE:CI) Shares Sold by Thrivent Financial for Lutherans

The Cigna Group logo with Medical background
Remove Ads

Thrivent Financial for Lutherans decreased its stake in The Cigna Group (NYSE:CI - Free Report) by 2.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 270,005 shares of the health services provider's stock after selling 6,014 shares during the quarter. Thrivent Financial for Lutherans owned about 0.10% of The Cigna Group worth $74,636,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. TCTC Holdings LLC purchased a new position in The Cigna Group during the 4th quarter valued at $25,000. Collier Financial purchased a new position in The Cigna Group in the 4th quarter worth about $32,000. ORG Wealth Partners LLC bought a new stake in The Cigna Group during the 4th quarter valued at about $34,000. Prospera Private Wealth LLC purchased a new stake in The Cigna Group in the 3rd quarter valued at about $37,000. Finally, Compagnie Lombard Odier SCmA bought a new position in The Cigna Group in the 4th quarter worth about $37,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. StockNews.com raised shares of The Cigna Group from a "hold" rating to a "buy" rating in a research note on Wednesday, February 19th. Sanford C. Bernstein cut The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 target price for the company. in a report on Thursday, February 6th. Royal Bank of Canada set a $355.00 price target on The Cigna Group in a research note on Friday, January 31st. Cantor Fitzgerald lifted their price objective on The Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a report on Thursday. Finally, Wells Fargo & Company dropped their target price on shares of The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a report on Tuesday, February 4th. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $373.25.

Remove Ads

Read Our Latest Research Report on CI

Insider Buying and Selling at The Cigna Group

In related news, insider Nicole S. Jones sold 4,904 shares of the business's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $1,511,020.48. Following the completion of the sale, the insider now owns 29,421 shares of the company's stock, valued at approximately $9,065,198.52. The trade was a 14.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Noelle K. Eder sold 9,944 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the transaction, the insider now directly owns 13,406 shares in the company, valued at approximately $4,289,920. The trade was a 42.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,751 shares of company stock valued at $13,603,991. 0.60% of the stock is owned by insiders.

The Cigna Group Stock Down 1.4 %

Shares of CI traded down $4.61 during midday trading on Friday, hitting $316.78. 3,552,779 shares of the company's stock traded hands, compared to its average volume of 1,566,129. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $86.70 billion, a price-to-earnings ratio of 25.88, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The firm's fifty day moving average is $300.83 and its 200-day moving average is $315.05.

The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the business posted $6.79 EPS. As a group, sell-side analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th were paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 1.91%. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date was Wednesday, March 5th. The Cigna Group's payout ratio is presently 49.35%.

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Should You Invest $1,000 in The Cigna Group Right Now?

Before you consider The Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.

While The Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads